SUPRIYA — Supriya Lifescience Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹59.81bn
- IN₹58.80bn
- IN₹6.96bn
- 83
- 11
- 90
- 70
Annual cashflow statement for Supriya Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1,673 | 2,072 | 1,235 | 1,657 | 2,485 |
| Depreciation | |||||
| Non-Cash Items | -9.22 | -29.1 | -46.1 | -134 | -67.1 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -973 | -1,657 | -645 | -548 | -975 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 759 | 488 | 662 | 1,133 | 1,647 |
| Capital Expenditures | -482 | -599 | -1,084 | -1,457 | -1,624 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 14.4 | 0.82 | -247 | -279 | 101 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -468 | -598 | -1,331 | -1,736 | -1,522 |
| Financing Cash Flow Items | 11.1 | 34.1 | 64.1 | -5.51 | -16.9 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -145 | 1,497 | -33.7 | -224 | -82.3 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 146 | 1,386 | -703 | -826 | 42 |